Luciferase Reporter Assay Kit |
K801-200 |
Biovision |
each |
EUR 235.2 |
Human IgG antibody Laboratories manufactures the dul reporter luciferase assay promega reagents distributed by Genprice. The Dul Reporter Luciferase Assay Promega reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Dul products are available in stock. Specificity: Dul Category: Reporter Group: Luciferase Assay
Double-Luciferase Reporter Assay Kit |
Abbexa |
200 µl |
EUR 900 |
Double-Luciferase Reporter Assay Kit |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Dual Luciferase Reporter Assay Kit |
Vazyme |
100 rxn |
EUR 90.5 |
Dual Luciferase Reporter Assay Kit |
Vazyme |
100 rxns |
EUR 93.71 |
Luciferase Reporter Gene Assay Kit |
Biochain |
200 assays |
EUR 329 |
Luciferase Reporter Gene Assay Kit |
Biochain |
500 assays |
EUR 636 |
Luciferase Reporter Gene Assay Kit |
Biochain |
1,000 assays |
EUR 1118 |
Luciferase Assay information
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Bright Glow* |
12537-100plates |
AAT Bioquest |
100 plates |
EUR 4447 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Luciferase Reporter Gene Assay Kit *Maximized Luminescence* |
12519 |
AAT Bioquest |
10 plates |
EUR 455 |
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Maximized Luminescence* |
12536 |
AAT Bioquest |
10 plates |
EUR 1092 |
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
IL-2 Promoter Luciferase Reporter Lentivirus |
79825 |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The IL-2 Promoter Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the human IL-2 promoter. After transduction, activation of the IL-2 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
IL-8 Promoter Luciferase Reporter Lentivirus |
79827 |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The IL-8 Promoter Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the human IL-8 promoter. After transduction, activation of the IL-8 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
ARE Luciferase Reporter Lentivirus |
79869 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Nrf2 antioxidant response pathway plays an important role in the cellular antioxidant defense. Nrf2, a basic leucine zipper transcription factor, induces the expression of antioxidant and phase II enzymes by binding to the ARE (antioxidant response element) region of the gene promoter. Under basal conditions, Nrf2 is retained in the cytosol by binding to the cytoskeletal protein Keap1. Upon exposure to oxidative stress or other ARE activators, Nrf2 is released from Keap1 and translocates to the nucleus, where it can bind to the ARE, leading to the expression of antioxidant and phase II enzymes that protect the cell from oxidative damage. The ARE Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by ARE located upstream of the minimal TATA promoter. After transduction, activation of the Nrf2 antioxidant response pathway in the target cells can be monitored by measuring the luciferase activity. |
SRE Luciferase Reporter Lentivirus |
78627 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The SRE (Serum Response Element) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Serum Response Element located upstream of the minimal TATA promoter . After transduction, activation of the MAPK/ERK signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Myc Luciferase Reporter Lentivirus |
78628 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Myc Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Myc response element located upstream of the minimal TATA promoter and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the Myc signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
p53 Luciferase Reporter Lentivirus |
78666 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The p53 Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by p53 response elements located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, p53-regulated gene expression in the target cells can be monitored by measuring the luciferase activity. |
HRE Luciferase Reporter Lentivirus |
78668 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Hypoxia Response Element (HRE) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of a hypoxia response elements (HRE) located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the induction of hypoxia in the target cells can be monitored by measuring the luciferase activity. |
TEAD Luciferase Reporter Lentivirus |
79833 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop cell proliferation and induce apoptosis. The mammalian Hippo pathway comprises MST kinases and LATS kinases. When the Hippo pathway is activated, MST kinases phosphorylate LATS kinases, which phosphorylate transcriptional co-activators YAP and TAZ. Unphosphorylated YAP and TAZ remain in nucleus and interact with TEAD/TEF transcriptional factors to turn on cell cycle-promoting gene transcription. However, when phosphorylated, YAP and TAZ are recruited from the nucleus to the cytosol, so that the YAP and TAZ-dependent gene transcription is turned off. Dysfunction of the Hippo pathway is frequently detected in human cancer and its down-regulation correlates with the aggressive properties of cancer cells and poor prognosis. The TEAD Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the TEAD response elements located upstream of the minimal TATA promoter. After transduction, activation of the Hippo pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT3 Luciferase Reporter Lentivirus |
79744 |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The STAT3 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT3-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT3 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT5 Luciferase Reporter Lentivirus |
79745 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The STAT5 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT5-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT5 signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Reporter (Luciferase) - THP-1 Cell Line |
78320 |
BPS Bioscience |
2 vials |
EUR 1810 |
Description: The NFAT reporter (Luciferase)-THP-1 cell line is designed for monitoring the NFAT (nuclear factor of activated T-cells) signaling pathway in THP-1 cells by measuring luciferase activity. It contains a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter. Upon activation by NFAT activators such as Ionomycin, endogenous NFAT transcription factors bind to the DNA response elements, inducing transcription of the luciferase reporter gene. |
NF-κB Luciferase Reporter Lentivirus |
79564 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The NF-κB Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of the NF-κB response element located upstream of the minimal TATA promoter. After transduction, activation of the NF-κB signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
CRE/CREB Luciferase Reporter Lentivirus |
79580 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The main role of the cAMP response element, or CRE, is mediating the effects of Protein Kinase A (PKA) by way of transcription. Upon phosphorylation, CREB forms a functionally active dimer that binds the CRE element within the promoters of target genes and activates transcription. CRE is at the focus of many extracellular and intracellular signaling pathways, including cAMP, calcium, GPCR (G-protein coupled receptors) and neurotrophins. The cAMP/PKA signaling pathway is critical to numerous life processes in living organisms.The CRE/CREB Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by multimerized cAMP response element (CRE) located upstream of the minimal TATA promoter. After transduction, activation of the cAMP/PKA signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Bald VSV Delta G (Luciferase Reporter) |
78636-1 |
BPS Bioscience |
100 µl |
EUR 395 |
Description: The bald VSV Delta G (Luciferase Reporter) was produced without envelope glycoproteins. It contains the firefly luciferase gene as the reporter. The bald VSV Delta G (Luciferase Reporter) can serve as a negative control when studying virus entry initiated by specific interactions between virus particles and receptors. |